Endonovo Therapeutics, Inc. (ENDV) stock
ENDVOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q/A on Dec 29, 2023
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $135.08KP/E –Yield –
Endonovo Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Endonovo Therapeutics's profit margin for the twelve months ending Sep 30, 2023 was -1722.2%. For fiscal 2022 it was -13649.2%, against -4247.2% the year before. The highest annual figure on record is -135.5% in fiscal 2010.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -13649.2% | −9402.0 |
| FY2021 | Dec 31, 2021 | -4247.2% | −4008.6 |
| FY2020 | Dec 31, 2020 | -238.6% | +5343.8 |
| FY2019 | Dec 31, 2019 | -5582.4% | +2147.2 |
| FY2018 | Dec 31, 2018 | -7729.5% | +150904.4 |
| FY2015 | Dec 31, 2015 | -158633.9% | −154667.7 |
| FY2014 | Dec 31, 2014 | -3966.2% | +8668.3 |
| FY2013 | Dec 31, 2013 | -12634.5% | −6373.9 |
| FY2012 | Dec 31, 2012 | -6260.6% | −6054.0 |
| FY2011 | Dec 31, 2011 | -206.6% | −71.0 |
| FY2010 | Dec 31, 2010 | -135.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | -50405.9% | −44900.8 |
| Q2 FY2023 | Jun 30, 2023 | 4565.6% | +393201.2 |
| Q1 FY2023 | Mar 31, 2023 | 8259.7% | +114009.4 |
| Q4 FY2022 | Dec 31, 2022 | -10647.0% | −768979.3 |
| Q3 FY2022 | Sep 30, 2022 | -5505.1% | +14054.2 |
| Q2 FY2022 | Jun 30, 2022 | -388635.5% | −384353.8 |
| Q1 FY2022 | Mar 31, 2022 | -105749.7% | −98027.2 |
| Q4 FY2021 | Dec 31, 2021 | 758332.3% | +775987.1 |
| Q3 FY2021 | Sep 30, 2021 | -19559.4% | −16885.4 |
| Q2 FY2021 | Jun 30, 2021 | -4281.7% | −619.1 |
| Q1 FY2021 | Mar 31, 2021 | -7722.5% | −13948.3 |
| Q4 FY2020 | Dec 31, 2020 | -17654.9% | −13838.9 |
| Q3 FY2020 | Sep 30, 2020 | -2673.9% | −71.8 |
| Q2 FY2020 | Jun 30, 2020 | -3662.6% | +8831.7 |
| Q1 FY2020 | Mar 31, 2020 | 6225.8% | +11578.6 |
| Q4 FY2019 | Dec 31, 2019 | -3815.9% | −7096.5 |
| Q3 FY2019 | Sep 30, 2019 | -2602.2% | +25315.8 |
| Q2 FY2019 | Jun 30, 2019 | -12494.3% | −2763.2 |
| Q1 FY2019 | Mar 31, 2019 | -5352.9% | +3524.3 |
| Q4 FY2018 | Dec 31, 2018 | 3280.5% | +20772.5 |
| Q3 FY2018 | Sep 30, 2018 | -27917.9% | −28376.4 |
| Q2 FY2018 | Jun 30, 2018 | -9731.1% | −8496.9 |
| Q1 FY2018 | Mar 31, 2018 | -8877.2% | −5338.0 |
| Q1 FY2015 | Mar 31, 2015 | -17492.0% | −14546.3 |
| Q3 FY2014 | Sep 30, 2014 | 458.5% | – |
| Q2 FY2014 | Jun 30, 2014 | -1234.2% | – |
| Q1 FY2014 | Mar 31, 2014 | -3539.1% | – |
| Q4 FY2013 | Dec 31, 2013 | -2945.7% | – |
See a number that looks wrong?